APA

Ferguson G. T., Tosiello R., Sanjar S. & Goodin T. (2018). Efficacy and Safety of Nebulized Glycopyrrolate/eFlow® Closed System in Patients with Moderate-to-Very-Severe Chronic Obstructive Pulmonary Disease with Pre-Existing Cardiovascular Risk Factors. : Chronic obstructive pulmonary diseases (Miami, Fla.).

Chicago

Ferguson Gary T, Tosiello Robert, Sanjar Shahin and Goodin Thomas. 2018. Efficacy and Safety of Nebulized Glycopyrrolate/eFlow® Closed System in Patients with Moderate-to-Very-Severe Chronic Obstructive Pulmonary Disease with Pre-Existing Cardiovascular Risk Factors. : Chronic obstructive pulmonary diseases (Miami, Fla.).

Harvard

Ferguson G. T., Tosiello R., Sanjar S. and Goodin T. (2018). Efficacy and Safety of Nebulized Glycopyrrolate/eFlow® Closed System in Patients with Moderate-to-Very-Severe Chronic Obstructive Pulmonary Disease with Pre-Existing Cardiovascular Risk Factors. : Chronic obstructive pulmonary diseases (Miami, Fla.).

MLA

Ferguson Gary T, Tosiello Robert, Sanjar Shahin and Goodin Thomas. Efficacy and Safety of Nebulized Glycopyrrolate/eFlow® Closed System in Patients with Moderate-to-Very-Severe Chronic Obstructive Pulmonary Disease with Pre-Existing Cardiovascular Risk Factors. : Chronic obstructive pulmonary diseases (Miami, Fla.). 2018.